2010
DOI: 10.1021/la1029432
|View full text |Cite
|
Sign up to set email alerts
|

Phospholipid-Stabilized Microbubble Foam for Injectable Oxygen Delivery

Abstract: A detailed study is presented on the synthesis and characterization of purely oxygen-filled microbubbles (OMBs) stabilized by phospholipids. Microbubbles with a diameter of less than 10 μm were generated and concentrated to >50 vol % in saline. The lipid acyl chain length had little effect on the size distribution but profoundly affected the foam stability. For example, OMBs stabilized by dipalmitoyl phosphatidylcholine (DPPC) degraded over 3 weeks, but OMBs stabilized with distearoyl phosphatidylcholine (DSPC… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
79
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 83 publications
(80 citation statements)
references
References 26 publications
1
79
0
Order By: Relevance
“…[17][18][19] Recently, there have been some reports regarding the use of microbubbles with special shell reagents for extending the duration of oxygen delivery using ultrasound for local drug delivery. [20][21][22][23][24] However, some problems still need to be resolved, such as the biocompatibility of the shell reagents, microbubble stability, and ultrasonographic damage to the body. Considering the clinical applications for oxygen delivery, an intravenous drip infusion is preferable because infusions possess the flexibility to be administered in large quantities at once and for long periods of time.…”
Section: Introductionmentioning
confidence: 99%
“…[17][18][19] Recently, there have been some reports regarding the use of microbubbles with special shell reagents for extending the duration of oxygen delivery using ultrasound for local drug delivery. [20][21][22][23][24] However, some problems still need to be resolved, such as the biocompatibility of the shell reagents, microbubble stability, and ultrasonographic damage to the body. Considering the clinical applications for oxygen delivery, an intravenous drip infusion is preferable because infusions possess the flexibility to be administered in large quantities at once and for long periods of time.…”
Section: Introductionmentioning
confidence: 99%
“…However, biocompatibility of the shell reagents and ultrasound damage to the body are major problems that remain to be solved, as also is microbubble stability (Juffermans et al 2006). Reports have also focused on special shell reagents for packing oxygen gas into microbubbles to extend the duration of oxygen delivery for injections (Cavalli et al 2009;Swanson et al 2010). In clinical applications of oxygen delivery to hypoxic patients, intravenous drip infusion is preferable because a large amount can be administered at once or over a long time.…”
Section: Introductionmentioning
confidence: 99%
“…Specifically, a lipid concentration of 10 mg/mL DSPC was necessary to achieve particle stability of at least 30 min consistently. Although, this concentration is higher than lipid concentrations used for the microfluidic manufacturing of liposomes reported in literature (0.3–3.5 mg/mL DSPC), this higher lipid concentration is similar to the concentration used in conventional batch manufacturing of ELIP with or without drug loading (Huang et al 2001, 2008; Swanson et al 2010; Thomson et al 2014). It has been demonstrated previously that increasing the acyl chain length increases the stiffness of microbubbles, resulting in higher resonance frequency and in vivo stability (Borden et al 2005).…”
Section: Discussionmentioning
confidence: 64%